SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2006-08-08
Filing Date Changed: 2006-08-29
Documents: 6
SEC Accession No.
0001193125-06-181130
Filing date: 2006-08-29
Accepted: 2006-08-29 10:27:29
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K d8k.htm 13792 FORM 8-K
2 EX-100.INS bmy-20060630.xml 51345 XBRL INSTANCE DOCUMENT
3 EX-100.SCH bmy-20060630.xsd 168242 XBRL TAXONOMY EXTENSION SCHEMA
4 EX-100.CAL bmy-20060630_cal.xml 856097 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
5 EX-100.LAB bmy-20060630_lab.xml 1052309 XBRL TAXONOMY EXTENSION LABEL LINKBASE
6 EX-100.PRE bmy-20060630_pre.xml 1384473 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
0001193125-06-181130.txt 3528620 Complete submission text file

Filer Information:

BRISTOL MYERS SQUIBB CO (Filer) (0000014272)
IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 061060687
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
345 PARK AVE
NEW YORK NY 10154
2125464000
 Mailing Address
345 PARK AVE
NEW YORK NY 10154